Unicycive Therapeutics (UNCY) Gets a Buy from Maxim GroupTip Ranks·Jul 14 at 03:25 AMUNCY-1.10%RANK-1.30%
UNCY INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Unicycive Therapeutics, Inc.MorningStar·Jul 8 at 07:11 PMUNCY-1.10%
Unicycive Therapeutics posts corporate presentation on kidney disease pipeline, lead hyperphosphatemia drug OLCPUBT·Jul 6 at 03:04 PMUNCY-1.10%
Unicycive Therapeutics Reports Preliminary Q2 2026 Cash PositionTip Ranks·Jul 2 at 09:58 AMUNCY-1.10%
Weekly Buzz: VRTX, APTX Gain FDA Nod; UNCY Disappoints; Ipsen Opens Wallet; VTGN Misses Goalrttnews·Jul 2 at 09:15 AMNVS-0.72%VRTX+0.90%
Guggenheim Remains a Buy on Unicycive Therapeutics (UNCY)Tip Ranks·Jul 1 at 05:55 AMUNCY-1.10%RILY-0.72%
US FDA rejects approval of Unicycive’s kidney disease therapyPharmaceutical Business Review·Jul 1 at 05:17 AMUNCY-1.10%
Unicycive Therapeutics 盘后跌超 10% 受 FDA 就制造缺陷发 CRL 影响US Stock Market Update·Jun 30 at 06:11 PMUNCY-1.10%
12 Health Care Stocks Moving In Tuesday's After-Market Sessionbenzinga_article·Jun 30 at 04:05 PMVVOS+0.64%UNCY-1.10%
Unicycive Therapeutics tumbles 8% after hours on FDA complete response letterUS Stock Market Update·Jun 30 at 03:51 PMUNCY-1.10%
Unicycive says FDA issues CRL for OLC NDA over third-party manufacturing deficienciesPUBT·Jun 30 at 06:05 AMUNCY-1.10%
12 Health Care Stocks Moving In Tuesday's Intraday Sessionbenzinga_article·Jun 30 at 12:05 PMCELZ-4.00%VTGN+0.18%
12 Health Care Stocks Moving In Tuesday's Pre-Market Sessionbenzinga_article·Jun 30 at 07:05 AMUPC-10.55%DCOY+2.02%